VRDN Operating Cash Flow Growth
Viridian Therapeutics Ors Inc · Operating Cash Flow Growth
VRDN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.86%period ending
VRDN TTM Cash from Operations YoY % (-89.50% → -7.86%)
Year-over-year change
High-resolution chart · PNG
VRDN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -7.8557% | |
| -8.4515% | |
| -18.9705% | |
| -65.4774% | |
| -83.678% | |
| -67.0941% | |
| -26.1438% | |
| -9.3085% | |
| -3.9327% | |
| -24.2274% | |
| -96.2638% | |
| -136.0928% | |
| -139.7089% | |
| -110.3005% | |
| -71.9243% | |
| -60.7578% | |
| -65.9394% | |
| -95.0272% | |
| -83.2869% | |
| -68.6809% | |
| -25.9274% | |
| -0.4678% | |
| 17.409% | |
| 22.7207% | |
| 4.8263% | |
| -4.5187% | |
| -34.3168% | |
| -40.5719% | |
| -37.0847% | |
| -14.4341% | |
| 4.697% | |
| -13.6441% | |
| -35.6533% | |
| -107.2847% | |
| -289.5312% | |
| -242.7176% | |
| -133.1418% | |
| -64.6736% | |
| -4.8275% | |
| -0.868% | |
| -52.9053% | |
| -135.1206% | |
| -211.7036% | |
| -319.0982% | |
| -393.0749% | |
| -376.5898% | |
| -89.5028% |